SEARCH

SEARCH BY CITATION

Cited in:

CrossRef

This article has been cited by:

  1. 1
    Katja Kollewe, Claus M. Escher, Dirk U. Wulff, Davood Fathi, Lejla Paracka, Bahram Mohammadi, Matthias Karst, Dirk Dressler, Long-term treatment of chronic migraine with OnabotulinumtoxinA: efficacy, quality of life and tolerability in a real-life setting, Journal of Neural Transmission, 2016, 123, 5, 533

    CrossRef

  2. 2
    Andrea Negro, Martina Curto, Luana Lionetto, Paolo Martelletti, A two years open-label prospective study of OnabotulinumtoxinA 195 U in medication overuse headache: a real-world experience, The Journal of Headache and Pain, 2015, 17, 1

    CrossRef

  3. 3
    Richard M. Kostrzewa, Rose Anna Kostrzewa, John P. Kostrzewa, Botulinum neurotoxin: Progress in negating its neurotoxicity; and in extending its therapeutic utility via molecular engineering. MiniReview, Peptides, 2015, 72, 80

    CrossRef

  4. 4
    Hyun-Mi Oh, Myung Chung, Botulinum Toxin for Neuropathic Pain: A Review of the Literature, Toxins, 2015, 7, 8, 3127

    CrossRef

  5. 5
    Siro Luvisetto, Parisa Gazerani, Carlo Cianchetti, Flaminia Pavone, Botulinum toxin Type A as a therapeutic agent against headache and related disorders, Toxins, 2015, 7, 9, 3818

    CrossRef

  6. 6
    László Vécsei, Zsófia Majláth, Délia Szok, Anett Csáti, János Tajti, Drug safety and tolerability in prophylactic migraine treatment, Expert Opinion on Drug Safety, 2015, 14, 5, 667

    CrossRef

  7. 7
    Rashid Kazerooni, Jane Lim, PharmD Ashley Blake, Stephanie Lessig, IncobotulinumtoxinA for Migraine: A Retrospective Case Series, Clinical Therapeutics, 2015, 37, 8, 1860

    CrossRef

  8. 8
    Edward Nahabet, Jeffrey E. Janis, Bahman Guyuron, Neurotoxins, Plastic and Reconstructive Surgery, 2015, 136, 104S

    CrossRef

  9. 9
    Stephen D Silberstein, David W Dodick, Sheena K Aurora, Hans-Christoph Diener, Ronald E DeGryse, Richard B Lipton, Catherine C Turkel, Per cent of patients with chronic migraine who responded per onabotulinumtoxinA treatment cycle: PREEMPT, Journal of Neurology, Neurosurgery & Psychiatry, 2015, 86, 9, 996

    CrossRef

  10. 10
    Nathan D. Zasler, Sports concussion headache, Brain Injury, 2015, 29, 2, 207

    CrossRef

  11. 11
    M. V. Naprienko, L. V. Smekalkina, Strategies on the improvement of chronic migraine treatment efficacy, Zhurnal nevrologii i psikhiatrii im. S.S. Korsakova, 2015, 115, 12, 70

    CrossRef

  12. 12
    Hyung-Jin Lee, Kwang-Seok Choi, Sung-Yoon Won, Prawit Apinuntrum, Kyung-Seok Hu, Seong-Taek Kim, Tanvaa Tansatit, Hee-Jin Kim, Topographic Relationship between the Supratrochlear Nerve and Corrugator Supercilii Muscle—Can This Anatomical Knowledge Improve the Response to Botulinum Toxin Injections in Chronic Migraine?, Toxins, 2015, 7, 7, 2629

    CrossRef

  13. 13
    Sara Schaefer, Christopher Gottschalk, Bahman Jabbari, Treatment of Chronic Migraine with Focus on Botulinum Neurotoxins, Toxins, 2015, 7, 7, 2615

    CrossRef

  14. 14
    Délia Szok, Anett Csáti, László Vécsei, János Tajti, Treatment of Chronic Migraine with OnabotulinumtoxinA: Mode of Action, Efficacy and Safety, Toxins, 2015, 7, 7, 2659

    CrossRef

  15. 15
    Robert G. Kaniecki, Frederick R. Taylor, Stephen H. Landy, Abstracts and Citations, Headache: The Journal of Head and Face Pain, 2014, 54, 4
  16. 16
    Gabriela R. Lauretti, Christiane P. Rosa, Antônio Kitayama, Bruno C. P. Lopes, Comparison of Botox<sup>®</sup> or Prosigne<sup>®</sup> and Facial Nerve Blockade as Adjuvant in Chronic Migraine, Journal of Biomedical Science and Engineering, 2014, 07, 08, 446

    CrossRef

  17. 17
    Scott M. Whitcup, Catherine C. Turkel, Ronald E. DeGryse, Mitchell F. Brin, Development of onabotulinumtoxinA for chronic migraine, Annals of the New York Academy of Sciences, 2014, 1329, 1
  18. 18
    Kayi Chan, Antoinette MaassenVanDenBrink, Glutamate Receptor Antagonists in the Management of Migraine, Drugs, 2014, 74, 11, 1165

    CrossRef

  19. 19
    C. Lia, P. Tosi, G. Giardini, L. Caligiana, E. Bottacchi, Onabotulinumtoxin A for prophylaxis in chronic migraine: preliminary data from headache regional centre of aosta valley, Neurological Sciences, 2014, 35, S1, 175

    CrossRef